Population screening for the common G985 mutation causing medium-chain acyl-CoA dehydrogenase deficiency with Eu-labeled oligonucleotides and the DELFIA system.

We have screened 10171 neonatal blood spots from the Trent and West Midlands regions of the UK for the common G985 mutation to more accurately establish the incidence of medium-chain acyl coenzyme (Co)A dehydrogenase (MCAD) deficiency. We have used a technique involving PCR and Eu-labeled allele-specific oligonucleotides detected by using time-resolved fluorometry on the dissociation-enhanced fluorescence immunoassay (DELFIA) system for the detection of the G985 mutation. We have also evaluated the feasibility of neonatal screening with this technique. We identified 158 G985 heterozygotes and no G985 homozygotes. The calculated incidence of MCAD deficiency in the population studied (all mutations, assuming 90% of MCAD mutations are G985) is 1 in 13426 (95% confidence limits 1 in 10070-1 in 18791). At the optimum cutoff criteria, the technique has a sensitivity of 97.5%, specificity of 99.6%, and positive predictive value of 80.2%. We conclude that this study confirms that MCAD deficiency is a common inherited metabolic disease and is a candidate for neonatal screening. The methodology used is robust and suitable for large-scale population studies such as this. The technique is also potentially suitable for screening.

[1]  B. Wilcken,et al.  Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency. , 1993, Archives of disease in childhood.

[2]  M. Mikola,et al.  Detection of a point mutation using short oligonucleotide probes in allele-specific hybridization. , 1994, BioTechniques.

[3]  Dong Hwan Lee.  Neonatal Screening for Inborn Errors of Metabolism , 1987 .

[4]  B. No̸rgaard-Pedersen,et al.  Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: An anonymous pilot study in Denmark , 1993 .

[5]  J. Leonard,et al.  Regional variations in medium-chain acyl-CoA dehydrogenase deficiency , 1995, The Lancet.

[6]  P. Fernhoff,et al.  Medium chain acyl‐CoA dehydrogenase deficiency: Human genome epidemiology review , 1999, Genetics in Medicine.

[7]  E. Naylor.  Biochemical versus molecular newborn screening , 1995 .

[8]  C. Charpentier,et al.  Medium chain acyl-CoA dehydrogenase deficiency. , 1992, Archives of disease in childhood.

[9]  S. Singhal,et al.  Fatal systemic lupus erythematosus in patient taking oral iron chelator L1 , 1991, The Lancet.

[10]  D. Hale,et al.  Fatty acid oxidation disorders: a new class of metabolic diseases. , 1992, The Journal of pediatrics.

[11]  L. Bolund,et al.  Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[12]  P. E. Johnson,et al.  Screening Newborns for Multiple Organic Acidurias in Dried Filter Paper Urine Samples: Method Development , 1991, Pediatric Research.

[13]  M. Bennett,et al.  Population Screening for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Analysis of Medium-Chain Fatty Acids and Acylglyeines in Blood Spots , 1994, Annals of clinical biochemistry.

[14]  S. Perrotta,et al.  Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels. , 1994, Journal of medical genetics.

[15]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[16]  S. Kolvraa,et al.  Frequency of the G985 MCAD mutation in the general population , 1991, The Lancet.

[17]  R. Ponzone,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. , 1993, Human heredity.

[18]  T. Lövgren,et al.  Europium-labeled oligonucleotides to detect point mutations: application to PIZ alpha 1-antitrypsin deficiency. , 1993, Clinical chemistry.

[19]  D. Danks,et al.  Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards , 1991, The Lancet.

[20]  D. Hall,et al.  Screening in infancy. , 1995, Archives of disease in childhood.

[21]  C. Roe,et al.  Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. , 1994, The Journal of pediatrics.

[22]  Mutations causing medium-chain acyl-CoA dehydrogenase deficiency: a collaborative compilation of the data from 172 patients. Workshop on Molecular Aspects of MCAD Deficiency. , 1992, Progress in clinical and biological research.